Khawaja Farhan J, Bailey Kent R, Turner Stephen T, Kardia Sharon L, Mosley Thomas H, Kullo Iftikhar J
Department of Internal Medicine, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Mayo Clin Proc. 2007 Jun;82(6):709-16. doi: 10.4065/82.6.709.
To investigate whether novel risk factors, including C-reactive protein (CRP), fibrinogen, lipoprotein(a) [Lp(a)], and homocysteine levels, are associated with the ankle brachial index (ABI) in African American and non-Hispanic white populations and whether novel risk factors account for ethnic differences in peripheral arterial disease (PAD).
Between December 2000 and October 2004, original participants in the Genetic Epidemiology Network of Arteriopathy study returned for a second study visit to undergo measurement of risk factors and ABI. The CRP, Lp(a), and homocysteine levels were log transformed to reduce skewness. Multivariable regression analyses were used to assess whether a novel risk factor was associated with ABI after adjustment for conventional risk factors and whether ethnicity was associated with PAD (ABI, <or=0.95) after adjustment for conventional and novel risk factors.
Of 2229 study participants, the ABI was determined in 1395 African American participants (mean +/- SD age, 63 +/- 9 years; 71% women) and 834 white participants (mean +/- SD age, 58 +/- 9 years; 62% women) who belonged to hypertensive sibships. The mean ABI was lower in African American than in white individuals (0.99 +/- 0.1 vs 1.13 +/- 0.1; P < .001). In both ethnic groups, higher levels of CRP, fibrinogen, and homocysteine were each associated with a lower ABI after adjustment for conventional risk factors. In African American participants, the Lp(a) level was also significantly associated with the ABI. African American ethnicity was associated with the presence of PAD after adjustment for conventional risk factors (men: odds ratio [OR], 3.04; 95% confidence interval [CI], 1.80-5.15; women: OR, 2.82; 95% CI, 1.85-4.29), but the risk was significantly attenuated after additional adjustment for novel risk factors (men: OR, 2.11; 95% CI, 1.21-3.70; women: OR, 1.98; 95% CI, 1.26-3.11).
Novel risk factors are associated with interindividual variation in ABI in African American and non-Hispanic white populations and partly account for the increased risk of PAD associated with African American ethnicity.
研究包括C反应蛋白(CRP)、纤维蛋白原、脂蛋白(a) [Lp(a)]和同型半胱氨酸水平在内的新型危险因素是否与非裔美国人和非西班牙裔白人人群的踝臂指数(ABI)相关,以及新型危险因素是否可解释外周动脉疾病(PAD)中的种族差异。
在2000年12月至2004年10月期间,动脉病遗传流行病学网络研究的原始参与者返回进行第二次研究访视,以测量危险因素和ABI。对CRP、Lp(a)和同型半胱氨酸水平进行对数转换以减少偏态。多变量回归分析用于评估在调整传统危险因素后新型危险因素是否与ABI相关,以及在调整传统和新型危险因素后种族是否与PAD(ABI≤0.95)相关。
在2229名研究参与者中,对1395名非裔美国参与者(平均±标准差年龄,63±9岁;71%为女性)和834名白人参与者(平均±标准差年龄,58±9岁;62%为女性)进行了ABI测定,这些参与者属于高血压同胞关系。非裔美国参与者的平均ABI低于白人(0.99±0.1对1.13±0.1;P<.001)。在两个种族群体中,调整传统危险因素后,较高水平的CRP、纤维蛋白原和同型半胱氨酸均与较低的ABI相关。在非裔美国参与者中,Lp(a)水平也与ABI显著相关。调整传统危险因素后,非裔美国人种族与PAD的存在相关(男性:比值比[OR],3.04;95%置信区间[CI],1.80 - 5.15;女性:OR,2.82;95%CI,1.85 - 4.29),但在进一步调整新型危险因素后,风险显著降低(男性:OR,2.11;95%CI,1.21 - 3.70;女性:OR,1.98;95%CI,1.26 - 3.11)。
新型危险因素与非裔美国人和非西班牙裔白人人群ABI的个体间差异相关,并部分解释了与非裔美国人种族相关的PAD风险增加。